Bioequivalence trials share

其中，新药临床试验2997项，占比57.5%，同比增长18%；生物等效性试验2218项，占比42.5%。

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

National Healthcare Security Administration. (2025). 国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升. Retrieved September 17, 2026, from http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Via StatOrigin, https://statorigin.org/stat/stat_HEBDQ5W4X21WJNF05KTYPFNKZQ

Copy

MLA

National Healthcare Security Administration. "国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升." 2025, http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_HEBDQ5W4X21WJNF05KTYPFNKZQ.

Copy

Chicago

National Healthcare Security Administration. "国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升." 2025. http://www.nhsa.gov.cn/art/2026/6/23/art_14_21076.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_HEBDQ5W4X21WJNF05KTYPFNKZQ.

Copy

BibTeX

@misc{nhsa2025bioequivalencepfnkzq, author = {{National Healthcare Security Administration}}, title = {国家医疗保障局 医保动态 从“0”到“1”创新能力增强 我国新药研发热度持续攀升}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_HEBDQ5W4X21WJNF05KTYPFNKZQ}, note = {Original source: http://www.nhsa.gov.cn/art/2026/6/23/art\_14\_21076.html. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_HEBDQ5W4X21WJNF05KTYPFNKZQ.